抗原碳水化合物125作为稳定慢性心力衰竭患者的预后生物标志物
Paula Guedes Ramallo1, Marina Martínez Moreno2,3, Andrea Romero Valero2,3
1Department of Cardiology, University Hospital of Canary Islands, Tenerife, Spain.
Cardiovascular diagnosis and therapy
|January 9, 2026
概括
在稳定的心力衰竭中,减少排气分数 (HFrEF),高碳水化合物抗原125 (CA125) 水平预测了住院和死亡率的增加. 这种生物标志物可能表明慢性HFrEF患者的残留拥堵和炎症.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏衰竭研究研究
背景情况:
- 碳水化合物抗原125 (CA125) 与急性心力衰竭 (HF) 的不良结果有关.
- 它在慢性,稳定的心力衰竭和减少喷射率 (HFrEF) 中的预后作用尚不清楚.
- 这项研究研究了CA125在临床稳定的HFrEF患者预测结果中的价值.
研究的目的:
- 为了确定血CA125水平的预后意义.
- 在稳定的HFrEF中评估CA125与死亡率和住院病人的关联.
- 探索CA125作为残留拥堵和炎症的潜在标志物.
主要方法:
- 一项前性队列研究对116名稳定的HFrEF患者进行了18个月的跟踪.
- 稳定性定义为没有HF入院或在前六个月内使用IV利尿剂.
- 结果包括所有原因的死亡率,HF入院和心血管 (CV) 入院.
- 著名的双变量波松回归分析了CA125与住院病人的关联.
主要成果:
- 较高的CA125水平 (>9.15U/mL) 与增加的HF入院 (IRR2.49) 和CV入院 (IRR1.88) 相关.
- 升高的CA125显示出与死亡风险增加的非线性关联 (P=0.02).
- CA125与较低的血清度,较大的下静脉腔直径和较高的炎症标志物相关.
结论:
- 在稳定的慢性HFrEF中,血CA125升高预测了中期发病率和死亡率的增加.
- CA125可以作为残留拥堵和炎症的替代标记.
- 这一发现凸显了CA125在管理稳定的HFrEF方面的潜在临床实用性.
更多相关视频
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
01:30Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
01:30Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
01:30Heart Failure IV: Classification and Diagnostic Evaluation
313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313